Skip to main content
Clinical Trials/JPRN-UMIN000031127
JPRN-UMIN000031127
Not yet recruiting
未知

An evaluation and an examination of the optimization of the cancer immunotherapy for advanced non-small cell lung cancer - IOB-LC1

Tohoku Medical and Pharmaceutical University,Tohoku Medical and Pharmaceutical University Hospital0 sites20 target enrollmentFebruary 5, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Patients with advanced non-small cell lung cancer who are going to receive a therapy with immune checkpoint Inhibitors
Sponsor
Tohoku Medical and Pharmaceutical University,Tohoku Medical and Pharmaceutical University Hospital
Enrollment
20
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 5, 2018
End Date
August 4, 2020
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Tohoku Medical and Pharmaceutical University,Tohoku Medical and Pharmaceutical University Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients having an overlap cancer with activity Patients that an doctor judged to be inappropriate

Outcomes

Primary Outcomes

Not specified

Similar Trials